Login / Signup

Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.

Heejoon JangSu Jong YuMark Hong LeeTae Min KimYun Bin LeeEun-Ju ChoJeong-Hoon LeeJung Hwan YoonYun Joon Kim
Published in: Journal of Korean medical science (2023)
ClinicalTrials.gov Identifier: NCT02585947.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • diffuse large b cell lymphoma
  • cross sectional